Research Areas
Health Sciences
Advising Theses
2020
2020Expertise In Medicine
Yeni tanı multipl myelomlu hastalarda indüksiyon tedavisi ile değişen performans, geriatrik değerlendirme ve kırılganlık testi sonuçlarının analizi
ÖZKURT Z. N. (Consultant)
K.DURMUŞ(Student)
2019
2019Expertise In Medicine
The Effect Of Comorbidity Scores And Geriatric Tests On The Results Of Autologous Stem Cell Transplantation Recipients
Özkurt Z. N. (Consultant)
M.KESTANE(Student)
2018
2018Expertise In Medicine
Toxicity of maintenance therapy in adult Acute Lymphoblastic Leucemia and evaluating effect of toxicity on survival outcomes, Gazi University Faculty of Medicine, Thesis in Internal Medicine
Özkurt Z. N. (Consultant)
M.ECEM(Student)
2015
2015Expertise In Medicine
Analysis of The Factors Associated With Mobilization Success in Allogeneic Stem Cell Donors
ÖZKURT Z. N. (Consultant)
L.BATMAZ(Student)
Published journal articles indexed by SCI, SSCI, and AHCI
2023
2023Analysis of bone marrow samples by the SYSMEX-XN20 hematology analyzer
KAYA Z., Kirkiz S., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
International Journal of Laboratory Hematology, vol.45, no.2, 2023 (SCI-Expanded)
2023
2023Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT
Waszczuk-Gajda A., Gras L., de Wreede L. C., Sirait T., Illes A., ÖZKURT Z. N., et al.
BONE MARROW TRANSPLANTATION, 2023 (SCI-Expanded)
2023
2023Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., SAVAŞ E. M., YILDIZ Ş., KÖK M. İ., ERDEMİR M. B., BOSTANKOLU DEĞİRMENCİ B., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2023 (SCI-Expanded)
2023
2023Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
AYGENCEL BIKMAZ Ş. G., Gökçe O., Haşimoğlu M., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., et al.
Turkish Journal of Medical Sciences, vol.53, no.1, pp.340-351, 2023 (SCI-Expanded)
2023
2023The Turkish perspective on apheresis activity: The Turkish apheresis registry report
Ozatli D., Giden A. O., ERKURT M. A., Korkmaz S., Basci S., Ulas T., et al.
Transfusion and Apheresis Science, 2023 (SCI-Expanded)
2022
2022Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis
Demirel K. D., ÖZKURT Z. N., Dogrul R. T., Kaynar L. A., YEGİN Z. A., GÖKER B., et al.
ANNALS OF HEMATOLOGY, vol.101, no.12, pp.2691-2697, 2022 (SCI-Expanded)
2022
2022Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia
BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
Leukemia Research, vol.118, 2022 (SCI-Expanded)
2022
2022Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia
AYDIN KAYNAR L., GÖKÇEN S., Can F., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY, vol.101, no.7, pp.1459-1464, 2022 (SCI-Expanded)
2022
2022Variable impact of graft CD3(+) cell content on graft versus host disease in hematopoietic stem cell transplant recipients: Is the role of donor CD3(+) cells overestimated?
YEGİN Z. A., BOSTANKOLU DEĞİRMENCİ B., YAZICI ŞENER G., SAVAŞ E. M., ÖZKURT Z. N., Koc H. N., et al.
TRANSFUSION AND APHERESIS SCIENCE, vol.61, no.3, 2022 (SCI-Expanded)
2022
2022Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION, vol.57, no.4, pp.633-640, 2022 (SCI-Expanded)
2022
2022Exercise capacity, physical activity and quality of life in patients with newly diagnosed hematologic malignancies: a cross-sectional study
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
PHYSIOTHERAPY THEORY AND PRACTICE, 2022 (SCI-Expanded)
2022
2022Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
CİVRİZ BOZDAĞ S., CENGİZ SEVAL G., Hindilerden I. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.
TURKISH JOURNAL OF HEMATOLOGY, vol.39, no.1, pp.43-54, 2022 (SCI-Expanded)
2021
2021Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
Barlas T., Inci K., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., GÜZEL TUNÇCAN Ö., Can F., et al.
Hematology (Amsterdam, Netherlands), vol.26, no.1, pp.328-339, 2021 (SCI-Expanded)
2021
2021Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
BONE MARROW TRANSPLANTATION, vol.56, no.11, pp.2820-2825, 2021 (SCI-Expanded)
2021
2021An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
Sevindik O. G., ÖZKURT Z. N., Boga C., Besisik S. K., Ipek Y., GEDÜK A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, 2021 (SCI-Expanded)
2021
2021Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Akay O. M., ÖZBALAK M. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
HEMATOLOGICAL ONCOLOGY, vol.39, no.4, pp.498-505, 2021 (SCI-Expanded)
2021
2021Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
Ozbalak M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, 2021 (SCI-Expanded)
2021
2021Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
YEGİN Z. A., ÖZKURT Z. N., DİKYAR A., AYDIN KAYNAR L., KARACAOĞLU YURDAGÜL Ö., Yagci M.
TRANSPLANTATION PROCEEDINGS, vol.53, no.6, pp.2013-2020, 2021 (SCI-Expanded)
2021
2021Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Sanz J., Labopin M., Sanz M. A., Aljurf M., Sousa A. B., Craddock C., et al.
BONE MARROW TRANSPLANTATION, vol.56, no.6, pp.1272-1280, 2021 (SCI-Expanded)
2021
2021Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION, vol.56, pp.133-134, 2021 (SCI-Expanded)
2021
2021Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders.
Colak M., Sarzhanova S., Yegin Z. A., Ozkurt Z. N., Fidan I., Bozdayi G.
Clinical lymphoma, myeloma & leukemia, vol.21, 2021 (SCI-Expanded)
2021
2021Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
AYGENCEL BIKMAZ Ş. G., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.4, pp.2095-2100, 2021 (SCI-Expanded)
2020
2020Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
BONE MARROW TRANSPLANTATION, vol.55, no.9, pp.1763-1772, 2020 (SCI-Expanded)
2020
2020Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders
Kalkancı A., Tuğ E., Fidan I., Güzel Tunçcan Ö., Özkurt Z. N., Yegin Z. A., et al.
MYCOSES, vol.63, pp.832-839, 2020 (SCI-Expanded)
2020
2020Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
HAEMATOLOGICA, vol.105, no.7, pp.1977-1983, 2020 (SCI-Expanded)
2020
2020The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., Can F., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., İLHAN Ç., et al.
Balkan medical journal, vol.37, no.3, pp.138-143, 2020 (SCI-Expanded)
2020
2020Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
FRONTIERS IN IMMUNOLOGY, vol.11, 2020 (SCI-Expanded)
2020
2020Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
BONE MARROW TRANSPLANTATION, vol.55, no.2, pp.393-399, 2020 (SCI-Expanded)
2020
2020Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Aydin Kaynar L., GÖKÇEN S., Eren Sadioglu R., ÖZKURT Z. N., et al.
HEMATOLOGY, vol.25, no.1, pp.125-133, 2020 (SCI-Expanded)
2019
2019A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Cremers E. M. P., de Witte T., de Wreede L., Eikema D., Koster L., van Biezen A., et al.
LEUKEMIA & LYMPHOMA, vol.60, no.10, pp.2404-2414, 2019 (SCI-Expanded)
2019
2019Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
Robin M., Chevret S., Koster L., Wolschke C., Yakoub-Agha I., Bourhis J. H., et al.
HAEMATOLOGICA, vol.104, no.6, pp.1230-1236, 2019 (SCI-Expanded)
2019
2019Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia
Mentese I. B., YEGİN Z. A., GÖKÇEN S., ÖZKURT Z. N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol.35, no.2, pp.265-271, 2019 (SCI-Expanded)
2018
2018Tuberculosis reactivation related with ruxolitinib in a patient with primary myelofibrosis
Pepeler M. S., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., AKYÜREK N.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.12, no.10, pp.926-928, 2018 (SCI-Expanded)
2018
2018Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
Pepeler M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.12, no.9, pp.799-805, 2018 (SCI-Expanded)
2018
2018Monoclonal B-cell lymphocytosis in blood donors in Turkey
Yagci M., YEGİN Z. A., Yenicesu I., Suyani E., Ulu B. U., Inci K., et al.
HEMATOLOGY, vol.23, no.1, pp.25-29, 2018 (SCI-Expanded)
2017
2017Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status
ÖZKURT Z. N., Batmaz L., YEGİN Z. A., İLHAN Ç.
TRANSFUSION AND APHERESIS SCIENCE, vol.56, no.3, pp.470-473, 2017 (SCI-Expanded)
2017
2017Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Haznedar R.
CANCER INVESTIGATION, vol.35, no.3, pp.195-201, 2017 (SCI-Expanded)
2016
2016A Rare and Mortal infection agent in patients with hematological malignancies: Saprochaete capitata Hematolojik Maligniteli Hastalarda Nadir ve Mortal Bir Enfeksiyon Etkeni: Saprochaete capitata
Aydin Kaynar L., ÖZKURT Z. N., Ulkuden B., GÜZEL TUNÇCAN Ö., Aygencel G., AKYÜREK N., et al.
Mikrobiyoloji Bulteni, vol.50, no.4, pp.613-620, 2016 (SCI-Expanded)
2016
2016A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
ÖZKURT Z. N., Suyani E., Haznedar R., Yagci M.
TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.3, pp.231-235, 2016 (SCI-Expanded)
2016
2016Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
KÖKTÜRK N., Yildirim F., AYDOĞDU M., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.1, pp.34-40, 2016 (SCI-Expanded)
2015
2015Acute myocardial infarction as a finding of acute promyelocytic leukemia-related coagulation disorder
ÖZKURT Z. N., Aypar E., Sarifakiogullari S., TAÇOY G., Ozdag M., Kahraman S., et al.
BLOOD COAGULATION & FIBRINOLYSIS, vol.26, no.8, pp.949-952, 2015 (SCI-Expanded)
2015
2015Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in immunosuppressive patients
Colak M., Altay A., ERTEN Y., ÖZKURT Z. N., Pynar A., Bozdayy G.
JOURNAL OF CLINICAL VIROLOGY, vol.70, 2015 (SCI-Expanded)
2015
2015Detection of EBV infection by real-time PCR method in immunosuppressive patients
Altay A., Colak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
JOURNAL OF CLINICAL VIROLOGY, vol.70, 2015 (SCI-Expanded)
2015
2015Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
Demirci T., YEGİN Z. A., Kursunoglu N., Yilmaz Z., Suyant E., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.1, pp.29-34, 2015 (SCI-Expanded)
2014
2014Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors
Acar K., Aki S. Z., ÖZKURT Z. N., BOZDAYI G., Rota S., Sucak G. T.
TURKISH JOURNAL OF HEMATOLOGY, vol.31, no.3, pp.276-285, 2014 (SCI-Expanded)
2014
2014A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis
Degertekin C. K., ÖZKURT Z. N., AKYÜREK N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol.30, 2014 (SCI-Expanded)
2013
2013TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia
Yagci M., YEGİN Z. A., AKYÜREK N., KAYHAN H., ÖZKURT Z. N., Sucak G. T., et al.
LEUKEMIA RESEARCH, vol.37, no.6, pp.665-670, 2013 (SCI-Expanded)
2012
2012The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation
Sucak G. T., Yasar D. G., YEGİN Z. A., ERGÜN M. A., ÖZKURT Z. N., Aki S. Z., et al.
ANNALS OF HEMATOLOGY, vol.91, no.8, pp.1281-1287, 2012 (SCI-Expanded)
2012
2012Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
Aydogdu M., Ozyilmaz E., Kokturk N., YEGİN Z. A., ÖZKURT Z. N., Aki Z. S., et al.
Minerva Medica, vol.103, no.3, pp.189-198, 2012 (SCI-Expanded)
2011
2011Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival
Sucak G. T., ÖZKURT Z. N., Suyani E., Yasar D. G., Akdemir O. U., Aki Z., et al.
ANNALS OF HEMATOLOGY, vol.90, no.11, pp.1329-1336, 2011 (SCI-Expanded)
2011
2011Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities
Aki S. Z., PAŞAOĞLU H., YEGİN Z. A., Suyani E., Demirtas C., ÖZKURT Z. N., et al.
HEMATOLOGY, vol.16, no.5, pp.284-290, 2011 (SCI-Expanded)
2011
2011Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation
Yegin Z. A., Pasaoglu H., Aki S. Z., Ozkurt Z. N., Demirtas C., Yagci M., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, vol.33, no.4, pp.414-423, 2011 (SCI-Expanded)
2011
2011Value of F-18-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma
Haznedar R., Aki S. Z., Akdemir O. U., ÖZKURT Z. N., Ceneli O., Yagci M., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.38, no.6, pp.1046-1053, 2011 (SCI-Expanded)
2011
2011Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
Suyani E., Sucak G. T., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY, vol.90, no.6, pp.685-691, 2011 (SCI-Expanded)
2010
2010Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
Sucak G., Suyani E., Ozkurt Z. N., Yegin Z. A., Aki Z., Yagci M.
HEMATOLOGICAL ONCOLOGY, vol.28, no.4, pp.180-184, 2010 (SCI-Expanded)
2010
2010Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload
Ozyilmaz E., Aydogdu M., Sucak G., Aki S. Z., Ozkurt Z. N., Yegin Z. A., et al.
BONE MARROW TRANSPLANTATION, vol.45, no.10, pp.1528-1533, 2010 (SCI-Expanded)
2010
2010The Impact of Bone Marrow Fibrosis on the Outcome of Hematopoietic Stem Cell Transplantation
Suyani E., Aki S. Z., Yegin Z. A., Ozkurt Z. N., Altindal S., Akyurek N., et al.
TRANSPLANTATION PROCEEDINGS, vol.42, no.7, pp.2713-2719, 2010 (SCI-Expanded)
2010
2010High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates
GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., ERBAŞ G., Aki S. Z., ŞENOL E., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.14, 2010 (SCI-Expanded)
2010
2010Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies
Yagci M., ÖZKURT Z. N., YEGİN Z. A., Aki Z., Sucak G. T., Haznedar R.
HEMATOLOGY, vol.15, no.4, pp.240-244, 2010 (SCI-Expanded)
2010
2010Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
YEGİN Z. A., ÖZKURT Z. N., Aki S. Z., Sucak G. T.
TRANSFUSION AND APHERESIS SCIENCE, vol.42, no.3, pp.239-245, 2010 (SCI-Expanded)
2010
2010Iron Overload: Predictor of Adverse Outcome in Hematopoietic Stem Cell Transplantation
Sucak G. T., Yegin Z. A., Ozkurt Z. N., Aki S. Z., Yagci M.
TRANSPLANTATION PROCEEDINGS, vol.42, no.5, pp.1841-1848, 2010 (SCI-Expanded)
2010
2010Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia
YEGİN Z. A., Ozkurt Z. N., Yaci M.
EUROPEAN JOURNAL OF HAEMATOLOGY, vol.84, no.5, pp.406-411, 2010 (SCI-Expanded)
2010
2010Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients
Ceneli O., ÖZKURT Z. N., Acar K., Rota S., Aki S. Z., YEGİN Z. A., et al.
WORLD JOURNAL OF GASTROENTEROLOGY, vol.16, no.14, pp.1765-1771, 2010 (SCI-Expanded)
2010
2010Thrombopoietic cytokines and platelet count in multiple myeloma
ÖZKURT Z. N., Yagci M., Sucak G. T., Kirazli S., Haznedar R.
PLATELETS, vol.21, no.1, pp.33-36, 2010 (SCI-Expanded)
2010
2010Factors Affecting Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplantation
ÖZKURT Z. N., YEGİN Z. A., Suyani E., Aki S. Z., Acar K., Yagci M., et al.
JOURNAL OF CLINICAL APHERESIS, vol.25, no.5, pp.280-286, 2010 (SCI-Expanded)
2009
2009Impact of ABO-Incompatible Donor on Early and Late Outcome of Hematopoietic Stem Cell Transplantation
Ozkurt Z. N., Yegin Z. A., Yenicesu I., Aki S. Z., Yagci M., Sucak G. T.
TRANSPLANTATION PROCEEDINGS, vol.41, no.9, pp.3851-3858, 2009 (SCI-Expanded)
2009
2009Diagnostic Usefulness Of Quantitative 18F-FDG PET/CT Data In The Detection Of Bone Marrow Involvement In Primary Staging Of Lymphoma Patients
Cakir T., Gokcora N., Akdemir Ü. Ö., Karabacak N., Akyurek N., Cakir A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.36, pp.241, 2009 (SCI-Expanded)
2009
2009Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Erdem O.
CUTANEOUS AND OCULAR TOXICOLOGY, vol.28, no.3, pp.141-143, 2009 (SCI-Expanded)
2009
2009Thrombopoietic Cytokine and P-Selectin Levels in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Decrease in Posttransplantation P-Selectin Levels Might Predict the Degree of Maximum Response
Aki S. Z., Sucak G. T., PAŞAOĞLU H., ÖZKURT Z. N., YEGİN Z. A., Ofluoglu E., et al.
CLINICAL LYMPHOMA & MYELOMA, vol.9, no.3, pp.229-233, 2009 (SCI-Expanded)
2009
2009Melanocortin-4 Receptor Gene Polymorphisms in Obese Patients
Yurtcu E., Yilmaz A., Ozkurt Z. N., Kolukisa E., Yilmaz M., KELEŞ H., et al.
BIOCHEMICAL GENETICS, vol.47, pp.295-300, 2009 (SCI-Expanded)
2009
2009Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem
Aki S. Z., Sucak G. T., ÖZKURT Z. N., YEGİN Z. A., Yagci M., Haznedar R.
TRANSFUSION AND APHERESIS SCIENCE, vol.40, no.1, pp.5-11, 2009 (SCI-Expanded)
2009
2009Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment
Konca C., Oezkurt Z. N., Deger M., Aki Z., Yagci M.
INTERNATIONAL JOURNAL OF HEMATOLOGY, vol.89, no.1, pp.58-62, 2009 (SCI-Expanded)
2009
2009The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women
Ozkurt B., ÖZKURT Z. N., Altay M., Aktekin C. N., ÇAĞLAYAN O., Tabak Y.
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY, vol.20, no.2, pp.78-84, 2009 (SCI-Expanded)
2008
2008The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak G. T., Yegin Z. A., Oezkurt Z. N., Aki S. Z., Karakan T., Akyol G.
BONE MARROW TRANSPLANTATION, vol.42, no.7, pp.461-467, 2008 (SCI-Expanded)
2008
2008Impact of adiponectin on left ventricular mass index in non-complicated obese subjects
Ebinc H., Ebninc F. A., ÖZKURT Z. N., DOĞRU M. T., Tulmac M., Yilmaz M., et al.
ENDOCRINE JOURNAL, vol.55, no.3, pp.523-528, 2008 (SCI-Expanded)
2008
2008Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: Risk factors for posttransplantation cardiac toxicity
Sucak G. T., Ozkurt Z. N., Aki Z., Yagci M., Cengel A., Haznedar R.
TRANSPLANTATION PROCEEDINGS, vol.40, no.5, pp.1586-1590, 2008 (SCI-Expanded)
2008
2008Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
Ebinc H., Ozkurt Z. N., Ebin F. A., Ucardag D., Caglayan O., Yilmaz M.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.36, no.1, pp.80-87, 2008 (SCI-Expanded)
2008
2008Adiponectin and insulin resistance in obesity-related diseases
Ebinc H., Ozkurt Z. N., Ebin F. A., Yilmaz M., Caglayan O.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.36, no.1, pp.71-79, 2008 (SCI-Expanded)
2007
2007Treatment of sinusoidal obstruction syndrome with defibrotide: A single-center experience
Sucak G. T., Aki Z. S., Yagci M., Yegin Z. A., Ozkurt Z. N., Haznedar R.
TRANSPLANTATION PROCEEDINGS, vol.39, no.5, pp.1558-1563, 2007 (SCI-Expanded)
2007
2007Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population
Guliter S., Yakaryilmaz F., Ozkurt Z. N., Ersoy R., Ucardag D., Caglayan O., et al.
WORLD JOURNAL OF GASTROENTEROLOGY, vol.13, no.10, pp.1599-1601, 2007 (SCI-Expanded)
2007
2007Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure
Ebinc H., Ebinc F. A., Ozkurt Z. N.
SAUDI MEDICAL JOURNAL, vol.28, no.3, pp.472-473, 2007 (SCI-Expanded)
2006
2006Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases
Sezikli M., Guliter S., Apan T. Z., Aksoy A., Keles H., Ozkurt Z. N.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.60, no.10, pp.1239-1243, 2006 (SCI-Expanded)
2006
2006Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals
Ebinc H., Ayerden Ebinc F., Nur Ozkurt Z. N., Dogru T., Yilmaz M.
ACTA CARDIOLOGICA, vol.61, no.4, pp.398-405, 2006 (SCI-Expanded)
2005
2005The relationship between atherosclerotic risk factors and carotid atherosclerosis in hemodialysis and peritoneal dialysis patients
Ozkurt Z. N., Bali M., Guz G., Ozdemir H., Cevik C., Sindel S.
DIALYSIS & TRANSPLANTATION, vol.34, no.12, pp.854-859, 2005 (SCI-Expanded)
2005
2005Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis
Ozkurt Z. N., Guliter S., Keles I., Keles H.
CLINICAL RHEUMATOLOGY, vol.24, no.6, pp.665-666, 2005 (SCI-Expanded)
2005
2005Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease
Altok K., Guz G., Ozdemir H., Erten Y., Atalay V., Bicik Z., et al.
INTERNATIONAL HEART JOURNAL, vol.46, no.2, pp.255-264, 2005 (SCI-Expanded)
Articles Published in Other Journals
2022
2022Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A., Labopin M., Swoboda R., Pioltelli P., Arat M., Yakoub-Agha I., et al.
HemaSphere, vol.6, no.11, 2022 (Peer-Reviewed Journal)
2022
2022Maintenance Therapy Toxicities, MTHFR and TPMT Genetic Polymorphism Analysis, and the Effect of Dose Manipulations on Survival Outcomes in Adult Patients with Turkish Acute Lymphoblastic Leukemia
Erdoğan Yön M. E., Özkurt Z. N., Gökçen S., Öcal R., Yegin Z. A., Yağcı A. M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları, vol.6, no.2, pp.29-37, 2022 (Peer-Reviewed Journal)
2022
2022Standart Prophylactic Granulocyte Colony Stimulating Factor Usage as a Part of Autologous Stem Cell Transplantati̇ on Procedure
AYDIN KAYNAR L., ÖZKURT Z. N., CAN F., YEGİN Z. A., GÜZEL TUNÇCAN Ö., YAĞCI A. M.
ACTA ONCOLOGICA TURCICA, vol.55, pp.52-57, 2022 (Peer-Reviewed Journal)
2021
2021Retrospective Evaluation of Effects of Preoperative Anaemia Treatment in Gynaecological and Obstetric Surgical Patients
Gunaydin B., Işik G., Bağcaz S., Inan G., Bozkurt N., Özkurt Z. N., et al.
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, vol.49, no.1, pp.25-29, 2021 (ESCI)
2020
2020Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
ÇOLAK M., Kocak A. A., Kaynar L. A., ÖZKURT Z. N., YEGİN Z. A., BOZDAYI G.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, vol.25, no.1, pp.40-46, 2020 (ESCI)
2020
2020Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
YEGİN Z. A., DİKYAR A., Kaynar L. A., Can F., ÖZKURT Z. N., Yagci M.
HEMATOLOGY REPORTS, vol.12, no.3, pp.51-54, 2020 (ESCI)
2018
2018Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
Colak M., Kocak A. A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
ISTANBUL MEDICAL JOURNAL, vol.19, no.1, pp.7-13, 2018 (ESCI)
2018
2018Capecitabine Induced Therapy Related Acute Myeloblastic Leukemia with t(10;11) (q22;q23) in a Patient with Breast Cancer
ÖZKURT Z. N., Ocal R., Pepeler M. S., Ulkuden B.
GAZI MEDICAL JOURNAL, vol.29, no.1, pp.57-58, 2018 (ESCI)
2018
2018İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişki
ÇOLAK M., ALTAY KOÇAK A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
Istanbul Medical Journal, vol.19, pp.7-13, 2018 (Peer-Reviewed Journal)
2018
2018İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişkiRelationship between Epstein-Barr Virus (EBV) İnfection and Viral Load in İmmunosuppressive Patients
ÇOLAK M., koçak a., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Med J, 2018 (Peer-Reviewed Journal)
2018
2018İmmunsupresif hastalarda EBV viral yükü ile klinik tablo arasında ilişki
altay koçak a., çolak m., dalgıç b., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Medical Journal, vol.19, pp.7-13, 2018 (Peer-Reviewed Journal)
2017
2017Ferritin is a predictor of prognosis in myelodysplastic syndrome?
YEGİN Z. A., HIZAL M., EREN SADİOĞLU R., ÖZKURT Z. N., Sucak G. T.
World Clin J Med Sci, vol.1, no.2, pp.89-95, 2017 (Peer-Reviewed Journal)
2017
2017Şiddetli eritrodermi ve dermatopatik lenfadenopati ile ortaya çıkan akut myeloid lösemi olgusu
öcal r., pepeler s., toker g., ÖZKURT Z. N.
LLM Dergi, vol.1, no.1, pp.18-21, 2017 (Peer-Reviewed Journal)
2017
2017Acute Myeloid Leukemia Presented with Severe Erythrodermia and Dermatopathic Lymphadenitis
ÖCAL R., ÖZKURT Z. N., pepeler m. s., toker g., YAĞCI A. M.
Lösemi Lenfoma Miyelom Araştırmaları Dergisi, vol.1, no.1, pp.18-21, 2017 (Peer-Reviewed Journal)
2017
2017Assessment of soluble entothelial protein c receptor and thrombomodulin levels in newly diagnosed myeloprolipherative neoplasms
çalkaya s., YEGİN Z. A., GÜLBAHAR Ö., ma ç., ÖZKURT Z. N., ACAR K., et al.
World Clin J Med Sci, vol.1, no.2, pp.84-88, 2017 (Peer-Reviewed Journal)
2015
2015Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report
TAÇOY G., Cengel A., ÖZKURT Z. N., TÜRKOĞLU S.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.43, no.1, pp.78-81, 2015 (ESCI)
2014
2014Relationship Between Teicoplanin Use and Increase in Minimal Inhibitor Concentrations of Coagulase-Negative Staphylococci
Güzel Tunçcan Ö., Dizbay M., Tozlu Keten D., Özkurt Z. N., Sucak G., Şenol E.
Gazi Medical Journal, vol.25, pp.97-99, 2014 (Scopus)
2007
2007Frequency of microalbuminuria and its relationship with other atherosclerotic risk factors in nondiabetic hypertensive patients
ÖZKURT Z. N., fatma e., KELEŞ H., EBİNÇ H., GÜLİTER S.
Anadolu Kardiyoloji Dergisi, 2007 (Peer-Reviewed Journal)
Refereed Congress / Symposium Publications in Proceedings
2020
2020Gastrointestinal sistem ve cilt tutulumu olan langerhans hücreli histiositoz: Olgu Sunumu
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., YAĞCI A. M.
6. Ege Hematoloji Onkoloji Kongresi, Turkey, 13 - 15 March 2020
2022
2022İnvaziv Pulmoner Aspergilloz Şüpheli Hastalarda Galaktomannan ve Beta Glukan Antijen Testlerinin Karşilaştir
ÇUHADAR T., KALKANCI A., GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., KÖKTÜRK N., et al.
XL. ULUSLARARASI TÜRK MIKROBIYOLOJI KONGRESI, Turkey, 16 November 2022
2022
2022The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients
Bostankolu Değirmenci B., Yegin Z. A., Dikyar A., Aydın Kaynar L., Özkurt Z. N., Uyar Göçün F. P., et al.
The 48 th Annual Meeting of the European Blood and Marrow, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.362-363
2022
2022Thiotepa-based reduced intensity conditioning are a valid alternative to total-body irradiation-based regimens in patients with acute lymphoblastic leukemia: A study of the alwp of the ebmt
Battıpaglıa G., L M., L S., R A., Özkurt Z. N., B J., et al.
the 48th Annual meeting of tha European Blood and Marrow Transplantation, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.163-164
2021
2021SeçilmişTirotoksikoz Olgularında Plazmaferez Tedavisi- Tek Merkez Deneyimi
Kahraman S. S., Yıldız B., Yalçın M. M., Sel A. T., Dikyar A., Eroğlu Altınova A., et al.
42. Endokrinoloji ve Metabolizma Hastalıkları Kongresi, 19 - 23 May 2021, pp.633
2020
2020The determinative role of patient-controlled-analgesia (PCA) in the early course of allogeneic hematopoietic stem cell transplantation
haşimoğlu k., can f., TERTEMİZ O. F., DİKYAR A., AKÇALI D. T., ÖZKURT Z. N., et al.
46th Annual meeting of European Society for Blood Marrow Transplantation: Physician Poster Session, United Kingdom, 29 August - 01 September 2020, vol.55, pp.181-714
2020
2020Gebelik ve Covid 19 ile tetiklenen TTP : Olgu Sunumu
AYDIN KAYNAR L., DİKYAR A., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
Hematoloji Uzmanlık Derneği Ulusal Kongresi, Turkey, 12 - 15 December 2020
2020
2020Covid-19 enfeksiyonunun hematolojik maligniteli hastalar üzerine etkileri
AYDIN KAYNAR L., GÜZEL TUNÇCAN Ö., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., ÖZKURT Z. N., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020
2020
2020Can Bone Marrow Cells Be Differentiated and Counted Using a Novel Hematology Analyzer?
KAYA Z., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
ISTH 2020, Venedik, Italy, 12 July 2020
2020
2020OKHN UYGULANMIŞ YÜKSEK RİSKLİ HL’DE BRENTUKSİMABVEDOTİN KONSOLİDASYONU GERÇEK YAŞAM VERİLERİ:ÇOK MERKEZLİ ÇALIŞMA
AKAY O. M., ÖZBALAK M. M., YILDIZ B., PEHLİVAN M., YİĞENOĞLU T., UZAY A., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.46
2020
2020Erişkin hemofili hastalarımızın analizi:Tek merkez deneyimi
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., DİKYAR A., YAĞCI A. M.
Hemofili vakalarla eğitim sempozyumu, Turkey, 21 - 23 February 2020
2019
2019“Infections in Hematopoietic Stem Cell Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital”
BARLAS T., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.66-67
2019
2019“Evaluation of Colistin-induced nephrotoxicity in critically-ill haematology patients”
AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., YEĞİN Z. A., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.47-48
2019
2019Infections in Hematopoietic StemCel Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital
Barlas T., Aygencel Bıkmaz Ş. G., Türkoğlu M., Can F., Aydın Kaynar L., Özkurt Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, Antalya, Turkey, 13 - 16 November 2019, vol.10, pp.66-67
2019
2019Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients – the Diadem Study from the Chronic Malignancies Working Party of the EBMT
Anna W., Wang J., Wreede L., Sirait T., ÖZKURT Z. N., Snowden J., et al.
61th ASH Annual Meeting, 7 - 10 December 2019
2019
2019Impact of vitamin D levels on peripheral stem cell mobilization in autologous hematopoietic stem cell transplant recipients
Can F., YEGİN Z. A., ÖZKURT Z. N., Akdogan O., Kaynar L. A.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.591-592
2019
2019Prognostic impact of pre-transplant TIM3 levels on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Kaynar L. A., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.161-162
2019
2019The impact of Pre-Transplant Cell-Free DNA levels on leukemia relapse and transplant related complications in allogeneic hematopoetic stem cell transplant recipients
YEGİN Z. A., CAN F., GÖKÇEN S., EREN SADİOĞLU R., ÖZKURT Z. N., İLHAN Ç., et al.
24th Congress of the European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019
2019
2019THE IMPACT OF PRE-TRANSPLANT CELL-FREE DNA LEVELS ON LEUKEMIA RELAPSE AND TRANSPLANT RELATED COMLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
YEGİN Z. A., CAN F., GÖKÇEN S., SADİOĞLU R. E., ÖZKURT Z. N., İLHAN Ç., et al.
24th European Hematology Association (EHA) Congress, Amsterdam, Netherlands, 13 - 16 June 2019
2019
2019COMPARISON OF CONSOLIDATION STRATEGIES IN ACUTE MYELOID LEUKEMIA: STANDARD CHEMOTHERAPYVS AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Dikyar A. A., Yeğin Z. A., CAN F., Kaynar L. A., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress on Leukemia Lymphoma Myeloma - 2019, İstanbul, Turkey, 3 - 05 May 2019, vol.1, pp.38-39
2019
2019MESENCHYMAL STEM CELL INFUSION IN GRAFT VERSUS HOST DISEASE:A SINGLE CENTER EXPERIENCE
AYDIN KAYNAR L., YÜCESU E., CAN F., DİKYAR A., İLHAN Ç., ÖZKURT Z. N., et al.
7th International Congress Leukemia Lymphoma Myeloma, 02 May 2019 - 04 May 2009
2019
2019EFFICACY OF HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUSHEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTSWITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
CAN F., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress Leukemia Lymphoma Myeloma, 2 - 04 May 2019
2019
2019hyperlactatemia,lactate clearance and outcome in critically ill patients with hematological malignencies
İNCİ K., GÖKÇE O., TÜRKOĞLU M., YAĞCI A. M., ÖZKURT Z. N., AYDIN KAYNAR L., et al.
22nd ınternational intensive care symposium, 1 - 02 May 2019
2019
2019second autologous hematopoietic stem cell transplant versus chemoimmunıtherapy in relapsed multiple myeloma after first transplantation : Single center data
CAN F., öcal r., AYDIN KAYNAR L., YEGİN Z. A., YAĞCI A. M., haznedar r., et al.
EBMT 2019 45Th Annual Meeting -, 23 - 27 March 2019
2017
2017Management and outcome of patients with diffuse large B-Cell lymphoma relapsed after autologous hematopoietic stem cell transplantation (auto-HSCT): A retrospective analysis of the lymphoma working party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
gonzalez e., boumendil a., blaise d., trneny m., masszi t., finel h., et al.
59th Annual Meeting Exposition, 9 - 12 December 2017
2018
2018Spinoserebellar Ataksili Hastada Miyelofibrozis Nedeniyle Yapılan Allojeneik Kök Hücre Nakli Sonrası Nörolojik İyileşme
Baltacı Z., Aydın Kaynar L., Yegin Z. A., Özkurt Z. N.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.368-369
2108
2108ERİŞKİNDE ALL İDAME TEDAVİ YAN ETKİLERİ, YAN ETKİ YÖNETİMİ VE YAN ETKİLERİN SAĞ KALIM İLE İLİŞKİSİ
MERVE ECEM E. Y., ÖCAL R., GÖKÇEN S., YEĞİN Z. A., YAĞCI A. M., ÖZKURT Z. N.
44. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October 2108 - 03 November 2018
2018
2018Is the End Close for the Graft-Versus-Host Disease That Is a Big Problem Following Allogeneic Hematopoetic Stem Cell Transplantation?
İLHAN O., Seval G. C., ÖZKURT Z. N., Ural A. U., Ayli M., Sevindik O. G., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132
2018
2018Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132
2018
2018Investigation of Epstein Barr Virus Infection in Patients with Acute Lymphoblastic Leukemia and Lymphoma
ÇOLAK M., SARZHANOVA S., ÖZKURT Z. N., FİDAN I., ÇAĞLAR K., BOZDAYI G.
21th Annual Meeting of the European Society for Clinical Virology Congress (ESCV), 23 - 26 September 2018
2018
2018Investigation of JCV positivity in patients with bone marrow transplant
ÇOLAK M., ALTAY KOÇAK A., Muftah H., ÖZKURT Z. N., Yeğin Z. A., BOZDAYI G.
21st Annual Meeting of European Society for Clinical Virology, Atina, Greece, 23 - 26 September 2018
2018
2018Upper extremity aerobic exercise training improves exercise capacity in stem cell recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52
2018
2018Exercise capacity, physical activity, quality of life in newly diagnosed hematologic malignancies
Çelik Z., Guclu M., Özkurt Z. N.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52
2018
2018In vivo T-cell depletion in patients with myelofibrosis transplanted from an HLA matched sibling donor: an EBMT study
Robin M., Chevret S., Koster L., Wolschke C., Yakoubagha I., Bourhis J., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.49-51
2018
2018Determinants of physical inactivity in hematopoietic stem cells recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52
2018
2018Exercise capacity, muscle strength and quality of life in physical active and inactive hematopoietic stem cells recipients
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
1st International Congress on Physiotechnotherapy, Sarajevo, Bosnia And Herzegovina, 9 - 13 May 2018
2018
2018Exercise capasity, muscle strength and quality of life in physical active and inactive hematopoietic stem cell recipients
bağrı g., güçlü m. b., ÖZKURT Z. N., YAĞCI A. M.
international Congress on Physiotechnoyherapy, Bosnia And Herzegovina, 9 - 13 May 2018, pp.43
2018
2018Hematopoetik Kök Hücre Nakli Alıcılarında Üst Ekstremite Aerobik Egzersiz Eğitiminin Kardiyopulmoner Sonuç Ölçümleri Üzerine Etkileri
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
Türk Toraks Derneği 21. Yıllık Kongresi, Antalya, Turkey, 11 - 15 April 2018
2017
2017Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130
2017
2017Hematopoetik Kök Hücre Nakli Alıcılarında Fiziksel Aktivite Seviyesi, Egzersiz Kapasitesi Ve Yaşam Kalitesi
BARĞI G., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 04 November 2017
2017
2017KRONİK MYELOSİTER LÖSEMİLİ HASTALARDA İMATİNİB TEDAVİSİNİN KESİLMESİ:ÇOK MERKEZLİ, İLERİYE DÖNÜK ÇALIŞMA 2.YIL SONUÇLARI
ÖZKURT Z. N., KARAKUŞ S., ÖCAL R., PEPELER M. S., GÖKÇEN S., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017
2017
2017Kronik Lenfositik Lösemi Patofizyolojisinde Nükleolin: Bir Apopitoz Belirteci Olabilir mi?
YEGİN Z. A., Pepeler S., KAYHAN H., ÖZKURT Z. N., GÖKÇEN S., YAĞCI A. M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017
2017
2017Esansiyel Trombositoz ve Primer Myelofibrozisli Hastalarda Kalretikülin Mutasyonu ve Kemik İliği Fibrozisi İlişkisi
ÇAKMAK G., KAYHAN H., GÖKÇEN S., ÖZKURT Z. N., YEGİN Z. A., HAZNEDAR R., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017
2017
2017Pulmonary functions, respiratory muscle strength and endurance in patients with newly diagnosed hematologic malignancy
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017
2017
2017Parvovirus B19 DNA Positivity in patients attended to a university hospital in Ankara, Turkey in 3 years process
ALTAY KOÇAK A., ÖZKURT Z. N., KARÇAALTINCABA D., BOZDAYI G.
20th Annual Meeting of the European Society for Clinical Virology, Stresa, Italy, 13 - 16 September 2017
2017
2017Comparison of matched-unrelated donors versus alternative donor (9/10) unrelated donor, cord blob unit and haplo-identical donor) in allogeneic stem cell transplantation (allo-SCT) for acute lymphoblastic leukemia (ALL) in CR2: a report of 841 patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France, 26 - 29 March 2017, vol.52
2017
2017PROGNOSTIC SIGNIFICANCE OF SERUM BAFF, APRIL, TACI AND BCMA LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Mentese I. B., Yegin Z. A., Gokcen S., Ozkurt Z. N., Yagci M.
22nd Congress of the European-Hematology-Association, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.720
2017
2017Erişkin yeni tanılanan akut lösemi hastalarında dispne, solunum fonksiyonları, depresyon ve yaşam kalitesi
BARĞI G., DÜNDAR Z. P., ÇELİK Z., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017
2017
2017Hematolojik maliniteli hastalarda solunum fonksiyonları, egzersiz kapasitesi, solunum kas kuvveti, aktivite dispnesi ve yorgunluğun sağlıklılarda karşılaştırılması
ÇELİK Z., BARĞI G., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017
2016
2016Abstract 3497 An Alternative Donor Is a Valid Option Compared to a Matched Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2 A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., myriam L., domenio r., sonja m., christoph s., bertram g., et al.
American Society of Hematology, 3 - 06 December 2016
2016
2016An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128
2016
2016Kronik Myelositer Lösemili Hastalarda İmatinib Tedavisinin Kesilmesi Çok merkezli ileriye dönük bir çalışma
YAĞCI A. M., ÖZKURT Z. N., GÖKÇEN S.
42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016
2016
2016Hematolojik Hastalığı Olan Bağışıklığı Baskılanmış Hastalarda Bronkoskopinin Tanısal Etkinliği
KÖKTÜRK N., YILDIRIM F., BAŞARIK AYDOĞAN B., KALKANCI A., GÜZEL TUNÇCAN Ö., AKI Ş. Z., et al.
Türk Toraks Derneği 19. Yıllık Kongresi, Antalya, Turkey, 6 - 10 April 2016
2016
2016Allojenik kök hücre alıcılarında gelişen viral hemorajik sistit tedavisinde Cidefovir ve Levofloksasin in etkinliği
Kaya a., Yeğin Z., Çolak M., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., Dağlı G.
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 3 - 05 March 2016
2016
2016Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M., ÖZKURT Z. N., YILDIZ Z., YEĞİN A., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
Hematoloji Kongresi, 1 - 04 March 2016
2016
2016Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M. S., Yildiz S., Yegin Z. A., Ozkurt Z. N., Tuncan O. G., Erbas G., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51
2015
2015İmmünsüprese hastalarda gerçek zamanlı polimeraz zincir reaksiyonu Real Time PCR ile polyomavirus DNA pozitifliğinin araştırılması
ÇOLAK M., ALTAY A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G., et al.
3. Ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015
2015
2015İmmünsüpresif hastalarda EBV enfeksiyonunun Real Time PCR yöntemi ile gösterilmesi
ALTAY A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
3. ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015
2015
2015Hematolojik maligniteli hastalarda yoğun bakım mortalitesine etkili faktörler
BOYACI N., Güllü Z., ÖZKURT Z. N., YAĞCI A. M., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015
2015
2015Hematolojik maligniteli hastalar için ayrı bir yoğun bakım ünitesi gerekli midir
BOYACI N., Güllü Z., ÖZKURT Z. N., YAĞCI A. M., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015
2015
2015Myeloproliferatif Hastalıklarda Tanı Anı Serum SEPCR ve Trombomodulin Düzeylerinin Değerlendirilmesi
çalkaya s., Yeğin Z. A., GÜLBAHAR Ö., ÖZKURT Z. N., ACAR K., Sucak G.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015
2015
2015Investigation of BK and JC virus DNA positivitiesby real time polymerase chain reaction inimmunosuppressive patients
Çolak M., Altay A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015
2015
2015Detection of EBV infection by real time PCRmethod in immunosuppressive patients
Altay A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015
2015
2015Detection of EBV infection by real timePCR method in immunosuppresive patients
Aylin A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of the European Society for Clinical Virology, 9 - 12 September 2015
2015
2015Diagnostic Yield Of Bronchoscopy In The Immunocompromised Patients With Haematological Disorders
Kokturk N., Yildirim F., Aydogan B. B., Kalkanci A., Tunccan Ö., Aki S. Z., et al.
International Conference of the American-Thoracic-Society (ATS), Colorado, United States Of America, 15 - 20 May 2015, vol.191
2010
2010Prognostic value of serum-free light chain monitoring in patients receiving autologous stem cell transplantation
Ozkurt Z. N., Haznedar R., Aki Z., Yagci M., Sucak G. T.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45
2009
2009THROMBOPOIETIC CYTOKINES AND PLATELET COUNT IN MULTIPLE MYELOMA
Ozkurt Z. N., Yagci M., Acar K., Sucak G. T., Haznedar R.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.618
2009
2009ABNORMAL SERUM FREE LIGHT CHAIN RATIO AS A PREDICTOR OF ADVERSE OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA: HAS THE TIME COME FOR A SIMPLE PROGNOSTIC MARKER?
Yegin Z. A., Yagci M., Ozkurt Z. N., Kursunoglu N., Aki S. Z.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.374
2009
2009CONTRIBUTION OF THALIDOMIDE MAINTENANCE TO LONG TERM RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
Ozkurt Z. N., Haznedar R., Yegin Z. A., Aki S. Z., Ceneli O., Yagci M., et al.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.387
2009
2009Adverse impact of iron overload on transplant outcome
Sucak G., Yegin Z. A., Ozkurt Z. N., Aki Z., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43
2009
2009impact of bone marrow fibrosis in the outcome of haematopoietic stem cell transplantation
Sucak G., Suyani E., Aki Z., Akyurek N., Ozkurt Z. N., Altindal S., et al.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43
2009
2009Vinorelbine and gemcitabine as a salvage regimen prior to stem cell transplantation in refractory or relapse Hodgkin's disease
Aki Z., Sucak G., Yegin A., Ozkurt Z. N., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43
2008
2008THE ROLE OF PRE-TRANSPLANTATION SERUM IRON PARAMETERS AND ANTI-OXIDATIVE POTENTIAL IN EARLY POSTTRANSPLANT TOXICITIES
Sucak G. T., Aki S. Z., Pasaoglu H., Ozkurt Z. N., Demirtas C., Yegin Z. A., et al.
13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.325-326
2005
2005Relationship of serum adiponectin level, anthropometric parameters and bone mineral density in postmenopausal
Ozkurt B., Ozkurt Z. N., Altay M., Aktekin C., Caglayan O., Tabak Y.
3rd Osteoporosis and Osteoarthritis Congress, Antalya, Turkey, 20 - 24 April 2005, vol.16, pp.2198
Books & Book Chapters
2018
2018Böbrek hastalılarında hematolojik değişiklikler
ÖZKURT Z. N.
in: HematoLog, Rauf Haznedar, Editor, Galenos, Ankara, pp.69-77, 2018
Supported Projects
2022 - 2025
2022 - 2025A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2022 - 2024
2022 - 2024Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2022 - 2024
2022 - 2024A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WHO ARE MINIMAL RESIDUAL DISEASE-POSITIVE AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive), Yıldız Ş.
2022 - 2024
2022 - 2024A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kδ Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2022 - 2024
2022 - 2024A Phase 2/3 Randomized, Controlled, Open-Label Study of KRT-232 in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post-ET-MF) who are Relapsed or Refractory to Janus Kinase (JAK) Inhibitor Treatment
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2021 - 2024
2021 - 2024Relaps/refrakter Multipl Myelomlu Gönüllülerde Pomalidomid+Bortezomib ve Deeksametazon ile kombinasyonda Belantamab Mafodotinin Etkinliğinin ve Güvenliğinin Değerlendirildiği Faz III Çok Merkezli Açık Etiketki Randomize Çalışma (DREAMM8)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2021 - 2024
2021 - 2024A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2017 - 2024
2017 - 2024Transplant için uygun olmayan yeni tanı konmuş multipl miyelom hastalarında, bortezomib (Velcade®), lenalidomid (Revlimid®) ve deksametazon ile kombinasyon halinde isatuksimabın (SAR650984) klinik yararını bortezomib, lenalidomid ve deksametazon ile karşılaştırmalı olarak değerlendiren Faz 3 randomize, açık etiketli, çok merkezli çalışma
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2020 - 2023
2020 - 2023A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2020 - 2021
2020 - 2021Ön tanı için yapay zeka destekli kan analiz sistemi
TUBITAK Project
Sayınalp N.(Executive), Hayran K. M., Özkurt Z. N.
2018 - 2019
2018 - 2019İnvaziv aspergilloz ve kandidoz gelişen kök hücre nakli alıcısı hematolojik maligniteli hastalarda TLR-4, PTX-3, Dectin-1 ve CARD9 genlerindeki tek nükleotid polimorfizmlerinin ve fungal enfeksiyonlara yatkınlığın retrospektif olarak araştırılması
Project Supported by Other Private Institutions
KALKANCI A. (Executive), TUĞ E., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., FİDAN I.
2017 - 2019
2017 - 2019MK-7018, çok merkezli ulusal , gözlemsel ilaç çalışması. Hematolojik malignensisi olan yüksek riskli hastalarda antifungal profilaksi: Uygulamanın klavuzlarla karşılaştırılması
Project Supported by Other Private Institutions
Güzel Tunçcan Ö. (Executive), Metan G.(Executive), Akan H., Ulu Kılıç A., İnkaya A. Ç., Özkurt Z. N., et al.
Tasks In Event Organizations
Mayıs 2022
Mayıs 20226. Gazi Hematoloji Günleri
Scientific Congress
Yağcı A. M., ÖZKURT Z. N.
Ankara, Turkey
Invited Talks
November 2022
November 2022Hematoloji Bilim Dalımız/Kliniğimiz Eğitim Programını Akredite Etmek İstiyoruz, Ne yapmalıyız?
Conference
Türk Hematoloji Derneği; 48. Ulısal Hematoloji Kongresi-Turkey
May 2022
May 2022Polistemi Vera
Conference
LLM Derneği; 2. LLM Kongresi-Turkey
March 2022
March 2022Allo-HKHN Sonrası Nüks AML: Proflaksi, Pre-emptif Yaklaşım ve Tedavi
Conference
Türk Hematoloji Derneği; 14. Ulusal Kök Hücre Kongresi-Turkey
March 2022
March 202210th Annual Meet the Experts of Transplanataion an Myeloma EBMT and TCT
Conference
Türk Kemik İliği Vakfı-Turkey
Citations
Total Citations (WOS): 798
h-index (WOS): 17
Jury Memberships
May-2022
May 2022